Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROMISE
2024-518724-72-00Phase 4Completed
- Sponsor
- Policlinico Gemelli
- Start
- Nov 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of warfarin, lysine acetylsalicylate, clopidogrel, aspirin, atorvastatin and 5 more in myocardial infarction with nonobstructive coronary arteries (MINOCA), sponsored by Policlinico Gemelli. Primary endpoint: Angina status and quality of life at 1 year. Started Nov 2024; status: completed.
02
Drugs
warfarinlysine acetylsalicylateclopidogrelaspirinatorvastatin
03
Conditions
myocardial infarction with nonobstructive coronary arteries (MINOCA)
Beyond the preview
Go deeper on 2024-518724-72-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518724-72-00.